Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2025-12-26 @ 4:26 AM
Study NCT ID:
NCT05060627
Status:
RECRUITING
Last Update Posted:
2022-09-08
First Post:
2021-09-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide
Sponsor:
Organization: